摘要
目的探析血浆置换术治疗不同严重度乙肝相关性肝衰竭(HBV-liver failure,HBV-LF)的临床效果。方法将2015年3月到2020年3月本院接治的125例HBV-LF患者纳入研究中,根据integrated终末期肝病模型(integrated model for End-Stage Liver Disease,iMELD)评分分为Ⅰ组(iMELD<35分),Ⅱ组(35分≤iMELD<45分)、Ⅲ组(45分≤iMELD<55分)、Ⅳ组(iMELD≥55分)四组。均采取血浆置换术治疗,对比分析有效率及治疗前后生化指标变化。结果I组有效率为93.55%,Ⅱ组为80.00%,Ⅲ组为61.76%,Ⅳ组为33.33%,组间差异有统计学意义(P<0.05)。治疗后Ⅰ组TBil、ALB、ALT、AST、PTA、INR均有显著变化,II组除ALB、Na+外,其余指标均有显著变化,Ⅲ组患者TBil、AST、ALT、PTA有显著变化,Ⅳ组ALT显著变化,均与同组治疗前差异有统计学意义(P<0.05)。结论血浆置换术治疗HBV-LF有确切效果,但病情越轻患者临床效果越佳。
Objective To explore the clinical effect of plasma exchange in the treatment of hepatitis B-related liver failure(HBV-LF).Methods 125 patients with HBV-LF admitted to our hospital from March 2015 to March 2020 were included in the study.According to the iMELD score,they were divided into four groups:groupⅠ(iMELD<35),group II(35≤iMELD<45),groupⅢ(45≤iMELD<55),and groupⅣ(iMELD≥55).All patients were treated with plasma exchange.The effective rate and biochemical indexes before and after treatment were compared and analyzed.Results The effective rate was 93.55%in group I,80.00%in groupⅡ,61.76%in groupⅢand 33.33%in groupⅣ.The difference was statistically significant(P<0.05).After treatment,TBiL,ALB,ALT,AST,PTA,INR in groupⅠwere significantly changed,except ALB and Na+in groupⅡ,TBIL,AST,ALT and PTA in groupⅢwere significantly changed,and ALT in groupⅣwas significantly changed,with statistically significant differences compared with those before treatment in the same group(P<0.05).Conclusion Plasma exchange is effective in the treatment of HBV-LF,but the lighter the patient’s condition is,the better the clinical effect is.
作者
郭惠惠
GUO Huihui(Department of Infectious Diseases,Chaoyang Branch of Zhangzhou Hospital Affiliated to Fujian Medical University,Zhangzhou Fujian 363000,China)
出处
《中国卫生标准管理》
2021年第2期35-38,共4页
China Health Standard Management
关键词
血浆置换术
终末期肝病
乙肝相关性肝衰竭
病重程度
血清学指标
肝功能
plasma replacement
end-stage liver disease
hepatitis B associated liver failure
severity of illness
serological indicators
liver function